ELF Patient Organisation Network

Swiss Sarcoidosis Association (SSARV – AscS)

www.sarkoidose.ch

www.sarcoidose.ch

Covers:

• Sarcoidosis

SASA exists to:

• increase public and professional awareness and understanding of Sleep Apnoea;
• promote research and the dissemination of the results; and
• provide support for Sleep Apnoea sufferers and their families.

Covers:

• Sleep apnoea

Covers:

• Adult asthma
• Allergies
• Asthma
• Bronchiectasis

Covers:

• Sleep apnoea
• Sleep disordered breathing

We work to improve the lives of sleep apnoea patients, their partners and their families. Founded in 1996 and funded by patients, SATA is a patient support charity run mainly by patient volunteers. As we are completely independent, we are the "Patients Voice". SATA achieves its goals through education, advocacy, raising awareness and assisting research and development.

Covers:

• Sleep apnoea

Voluntary organisation providing information, support and advocacy for people (and their families) suffering from respiratory sleep disorders and sleep disorders in general.

Covers:

• Sleep apnoea

Covers:

• Pulmonary Hypertension

The Spanish Cystic Fibrosis Federation (FEFQ) is an organisation that brings together and represents 15 Cystic Fibrosis associations from all over Spain. The mission is to bring together CF associations to work together to improve the quality of life of people with CF and their families. In addition, FEFQ want CF to be a disease that is known and led by a strongly united federation that represents all the associations and is their main support.

Covers:

• Cystic fibrosis

Pulmonary Hypertension Association the Netherlands

Covers:

• Pulmonary Hypertension

Stitching PIBO is a non-profit organisation dedicated to improving the diagnosis and treatment of Post-Infectious Bronchiolitis Obliterans (PIBO), especially in young children. They aim to raise awareness among parents and healthcare professionals, and support scientific research into its causes and consequences.

Covers:

• Interstitial lung disease
• Rare and orphan lung disease

As charitable foundation, we focus particularly on children and adolescents with post-infectious Bronchiolitis obliterans and Bronchiolitis obliterans Syndrom. Our dedication is to inform, support and help affected children and their families, and to link with specialized centers. In cooperation with the Childrens‘ University Hospital Frankfurt we support research projects that will lead to improvements in long-term outcome of affected patients.

Covers:

• Bronchiectasis
• Bronchiolitis
• Bronchopulmonary dysplasia
• Interstitial lung disease
• Rare and orphan lung disease

TB Europe Coalition (TBEC) is a regional advocacy network of civil society organisations and individuals in the WHO Europe region committed to end tuberculosis (TB). The network aims to strengthen the role of civil society within the regional response to TB, and ensure political and financial commitments to end TB.

Covers:

• Acute lower respiratory infections
• Acute respiratory distress syndrome
• Adult asthma
• Allergies
• Alpha-1 antitrypsin deficiency
• Asthma
• Bronchiectasis
• ChILD
• Childhood asthma
• COPD
• Cough
• COVID-19
• Cystic fibrosis
• Idiopathic pulmonary fibrosis
• Interstitial lung disease
• LAM
• Lung cancer
• Lung disease in children
• Lung surgery
• Lung transplantation
• Mesothelioma
• Non-tuberculosis mycobacteria
• Occupational lung disease
• Other lung diseases
• Pneumonia
• Pneumothorax
• Primary Ciliary Dyskinesia (PCD)
• Pulmonary arterial hypertension
• Pulmonary embolism
• Pulmonary Fibrosis
• Pulmonary Hypertension
• Pulmonary vascular disease
• Rare and orphan lung disease
• Sarcoidosis
• Sleep apnoea
• Sleep disordered breathing
• Smoking cessation
• Tuberculosis
• Upper airways diseases

The Association for Supporting MDR TB Patients (ASPTMR) started a support group for MDR patients in 2011. Now, they provide direct services for over 4000 TB patients. ASPTMR also advocate for those with TB and contribute to the TB Law in Romania.

Covers:

• Tuberculosis

The BHD Foundation offers a number of creative and useful resources to inform, empower and build up the BHD community, such as interviews with researchers and people affected by BHD, patient advocacy and creating public and patient-friendly information on the condition. It is directed towards families affected by BHD as well as researchers and health professionals.

Covers:

• Rare and orphan lung disease

The LAM Foundation urgently seeks safe and effective treatments, and ultimately a cure, for lymphangioleiomyomatosis (LAM) through advocacy and the funding of promising research. We are dedicated to serving the scientific, medical and patient communities by offering information, resources and a worldwide network of hope and support.

Covers:

• LAM
• Rare and orphan lung disease

Tracheo-Oesophageal Fistula Support (TOFS) offers support to all people born with the rare congenital conditions oesophageal atresia (OA) and tracheo-oesophageal fistula (TOF), commonly known as OA/TOF.  These conditions strike people across all ethnicities and personal situations, and the impacts are often lifelong.  Approximately 190 OA/TOF babies are born each year in the UK, and T.O.F.S. estimates the UK population of OA/TOF people as about 3500 children and 7500 adults.  T.O.F.S is a membership organisation registered as a charity and company limited by guarantee.  It is the largest English-speaking OA/TOF support group in the world. The majority of our membership lives is in the UK, but T.O.F.S has members in 70 countries worldwide. Our membership grows on average by 270 new members annually. Our mission is for those born with OA/TOF to be able to live unlimited, unconstrained by the impact of being born with these conditions.

Covers:

• Acute lower respiratory infections
• Bronchiectasis
• Rare and orphan lung disease
• Upper airways diseases

The Turkey SMA Foundation aims to ensure the active participation of individuals with SMA in our country in social life, to carry out activities that support the activities to be carried out by considering the benefit of patients and their families.

Covers:

• Lung disease in children
• Other lung diseases